Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

A doctor may prescribe ketorolac (Toradol), an NSAID available as a nasal spray, to help manage migraine attacks that cause severe pain. They may also recommend ketorolac as a rescue medication if ...

If approved, the nasal spray formulation would provide an additional ... A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application.